TY - JOUR T1 - Automated Bias Reduction in Deep Learning Based Melanoma Diagnosis using a Semi-Supervised Algorithm JF - medRxiv DO - 10.1101/2021.01.13.21249774 SP - 2021.01.13.21249774 AU - Sauman Das Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/01/2021.01.13.21249774.abstract N2 - Melanoma is one of the most fatal forms of skin cancer and is often very difficult to differentiate from other benign skin lesions. However, if detected at its early stages, it can almost always be cured. Researchers and data scientists have studied this disease in-depth with the help of large datasets containing high-quality dermascopic images, such as those assembled by the International Skin Imaging Collaboration (ISIC). However, these images often lack diversity and over-represent patients with very common skin features such as light skin and having no visible body hair. In this study, we introduce a novel architecture called LatentNet which automatically detects over-represented features and reduces their weights during training. We tested our model on four distinct categories - three skin color levels corresponding to Type I, II, and III on the Fitzpatrick Scale, and images containing visible hair. We then compared the accuracy against the conventional Deep Convolutional Neural Network (DCNN) model trained using the standard approach (i.e. without detecting over-represented features) and containing the same hyper-parameters as the LatentNet. LatentNet showed significant performance improvement over the standard DCNN model with accuracy of 89.52%, 79.05%, 64.31%, and 64.35% compared to the DCNN accuracy of 90.41%, 70.82%, 45.28%, 56.52% in the corresponding categories, respectively. Differences in the average performance between the models were statistically significant (p < 0.05), suggesting that the proposed model successfully reduced bias amongst the tested categories. LatentNet is the first architecture that addresses racial bias (and other sources of bias) in deep-learning based Melanoma diagnosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that supports the findings of this study are openly available from the International Skin Imaging Collaboration archives. https://challenge2020.isic-archive.com/ https://challenge2018.isic-archive.com/ ER -